Xavier Harland

Xavier Harland has a diverse work experience in finance and management roles. Xavier is currently working as the Chief Financial Officer at FlipNpik North America since 2022. Prior to this, they served as the Chief Financial Officer at Groupe Mainland starting from 2014. In 2016, they became the President of Gestion Conseil Harland, while also holding positions as a Member of Anges Québec, THORASYS Thoracic Medical Systems Inc., and Greatify.co. Xavier was also the President of Gestion GFX from 2014 until 2022. Additionally, they served as the Chairman and CFO at FlipNpik, North America, from 2018 to 2019. Before that, they were a Member of the Board of Directors at Feldan Bio from 2015 to 2018 and served as the Chief Financial Officer of Acasti Pharma, Inc. from 2011 to 2014.

Xavier Harland's education history is as follows:

From 2016 to 2018, Xavier completed an Executive MBA program at EMBA McGill HEC Montréal, focusing on Business Administration.

Between 2000 and 2003, they attended Université Laval, where they obtained a Bachelor's degree in Science with a specialization in Actuarial Science.

From 1993 to 1998, Xavier attended St-Sacrement, although no specific degree or field of study was mentioned for this period.

In addition to their formal education, Xavier has obtained several certifications. In 2020, they completed a course on Data Science in Real Estate at the MIT School of Architecture and Planning. In 2018, they achieved a Continuing Education Program milestone from the CFA Institute. Xavier also holds the FRM certification from GARP Research & Securities, although the exact date of completion was not provided. Finally, in 2007, they obtained the CFA designation from the CFA Institute.